Trial Profile
Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Abciximab (Primary) ; Reteplase
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms CARESS
- 26 Aug 2009 New trial record